452 results Compensation after infringement of the General Data Protection Regulation: European developments The General Data Protection Regulation (GDPR) is one of the most significant development in the European data strategy in the past years and is continuously evolving. Een inbreuk op de AVG geeft niet zonder meer recht op schadevergoeding: Europese ontwikkelingen De Algemene Verordening Gegevensbescherming (de “AVG”) is één van de meest ingrijpende ontwikkelingen binnen de Europese datastrategie van de afgelopen jaren en nog steeds volop in ontwikkeling. Een jaar privacy-toezicht verantwoord: Dit zegt het jaarverslag van de AP De AP legt in haar jaarverslag verantwoording af over 2024. Het jaar kenmerkte zich door een mix van strenge handhaving én stimulerende maatregelen om naleving te bevorderen. Wat kan uw organisatie hiervan leren? Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property. The Current Status of the AI Act: Navigating the Future of AI Regulation in the EU We discuss the current status of the AI Act since the ban on unacceptable AI systems and the AI literacy obligation, and the challenges that are arising in light of the balance between the rapid advancement of technologies and the slow pace of regulation. EU-U.S. Data Privacy Framework: A new adequacy decision for the United States On Monday July 10, 2023, the European Commission adopted her adequacy decision for the United States, the “EU-U.S. Data Privacy Framework”, which has immediate effect. Three months after the UBO-case – Where do we stand and what’s next? This article looks at the aftermath of the UBO case invalidating the general access to UBO data, and looks at what lies ahead for companies and member states, and specifically at Belgium's recent regulatory action. Key Insights Stibbe Equity Capital Markets Seminar 2025 On Thursday 19 June 2025, Stibbe hosted its annual Equity Capital Markets Seminar. The gathering, hosted by Pieter Schütte and Nora Offergelt, was attended by over 70 capital markets participants. Stibbe assists Qrf with triple win Stibbe advised Qrf on two strategic real estate acquisitions and assisted the company with its capital raise to partially finance these transactions. Equity raises: prospectus exemptions and share issuance approvals In this note we discuss the interplay between prospectus exemptions and share issuance authorisations of listed Dutch companies. Prospectus exemptions are expanded under the EU Listing Act, but will Dutch issuers be able to take full advantage? Commission publishes PSD3 and PSR Proposal; a tightening of the regulation of payment services providers in the EU On June 28, 2023, the European Commission published a set of new legislative proposals, including PSD3, aimed at ushering in the digital era for payments and the broader financial sector, with a particular focus on consumers. EU Listing Act: Market Soundings Regime Market soundings are a tool for issuers and financial market participants to gauge investor interest in potential transactions before they are publicly announced. These interactions often involve sharing inside information as defined by the MAR. ESG disclosure in equity prospectuses: current state of affairs In a world where ESG takes centre stage, equity prospectuses will need to include disclosure on all material ESG-related matters. Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period. Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment. EU Listing Act enters into force 4 December 2024 The EU Listing Act, which includes updates to the Prospectus Regulation, Market Abuse Regulation, Markets in Financial Instruments Regulation, and to the Markets in Financial Instruments Directive, has been published on 14 November 2024. Listing Act: Inside information disclosure in a protracted process In April 2024, the European Parliament adopted the EU Listing Act. We discuss the removal of the obligation to immediately disclose an intermediate step in a protracted process that constitutes inside information under the Market Abuse Regulation. Cross-border corporate lending into the Netherlands Cross-border corporate lending is set for change as CRD VI introduces new licensing obligations, requiring non-EU lenders to reassess their activities in the Netherlands and the EU for all in scope contracts signed on or after 11 July 2026. Pagination Previous page Page 23 Current page 24 Page 25 Page 26 Next page
Compensation after infringement of the General Data Protection Regulation: European developments The General Data Protection Regulation (GDPR) is one of the most significant development in the European data strategy in the past years and is continuously evolving.
Een inbreuk op de AVG geeft niet zonder meer recht op schadevergoeding: Europese ontwikkelingen De Algemene Verordening Gegevensbescherming (de “AVG”) is één van de meest ingrijpende ontwikkelingen binnen de Europese datastrategie van de afgelopen jaren en nog steeds volop in ontwikkeling.
Een jaar privacy-toezicht verantwoord: Dit zegt het jaarverslag van de AP De AP legt in haar jaarverslag verantwoording af over 2024. Het jaar kenmerkte zich door een mix van strenge handhaving én stimulerende maatregelen om naleving te bevorderen. Wat kan uw organisatie hiervan leren?
Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.
The Current Status of the AI Act: Navigating the Future of AI Regulation in the EU We discuss the current status of the AI Act since the ban on unacceptable AI systems and the AI literacy obligation, and the challenges that are arising in light of the balance between the rapid advancement of technologies and the slow pace of regulation.
EU-U.S. Data Privacy Framework: A new adequacy decision for the United States On Monday July 10, 2023, the European Commission adopted her adequacy decision for the United States, the “EU-U.S. Data Privacy Framework”, which has immediate effect.
Three months after the UBO-case – Where do we stand and what’s next? This article looks at the aftermath of the UBO case invalidating the general access to UBO data, and looks at what lies ahead for companies and member states, and specifically at Belgium's recent regulatory action.
Key Insights Stibbe Equity Capital Markets Seminar 2025 On Thursday 19 June 2025, Stibbe hosted its annual Equity Capital Markets Seminar. The gathering, hosted by Pieter Schütte and Nora Offergelt, was attended by over 70 capital markets participants.
Stibbe assists Qrf with triple win Stibbe advised Qrf on two strategic real estate acquisitions and assisted the company with its capital raise to partially finance these transactions.
Equity raises: prospectus exemptions and share issuance approvals In this note we discuss the interplay between prospectus exemptions and share issuance authorisations of listed Dutch companies. Prospectus exemptions are expanded under the EU Listing Act, but will Dutch issuers be able to take full advantage?
Commission publishes PSD3 and PSR Proposal; a tightening of the regulation of payment services providers in the EU On June 28, 2023, the European Commission published a set of new legislative proposals, including PSD3, aimed at ushering in the digital era for payments and the broader financial sector, with a particular focus on consumers.
EU Listing Act: Market Soundings Regime Market soundings are a tool for issuers and financial market participants to gauge investor interest in potential transactions before they are publicly announced. These interactions often involve sharing inside information as defined by the MAR.
ESG disclosure in equity prospectuses: current state of affairs In a world where ESG takes centre stage, equity prospectuses will need to include disclosure on all material ESG-related matters.
Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period.
Listing Act: reversing MiFID II's unbundling regime – is it enough? The Listing Act rolls back the unbundling requirements introduced by MiFID II by once again permitting joint payments for investment research and execution services. In this article, we address the background and practical implications of this amendment.
EU Listing Act enters into force 4 December 2024 The EU Listing Act, which includes updates to the Prospectus Regulation, Market Abuse Regulation, Markets in Financial Instruments Regulation, and to the Markets in Financial Instruments Directive, has been published on 14 November 2024.
Listing Act: Inside information disclosure in a protracted process In April 2024, the European Parliament adopted the EU Listing Act. We discuss the removal of the obligation to immediately disclose an intermediate step in a protracted process that constitutes inside information under the Market Abuse Regulation.
Cross-border corporate lending into the Netherlands Cross-border corporate lending is set for change as CRD VI introduces new licensing obligations, requiring non-EU lenders to reassess their activities in the Netherlands and the EU for all in scope contracts signed on or after 11 July 2026.